CASSIOPEIA: A phase 2 study evaluating efficacy and safety of tisagenlecleucel in first-line therapy for high-risk pediatric and young adult patients with B-cell Acute Lymphoblastic Leukemia (B-ALL) who are MRD positive at the End of Consolidation (EOC)
ONCOLOGY RESEARCH AND TREATMENT(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要